Cipla informs about disclosure

27 Jul 2022 Evaluate
Cipla has informed that lnvaGen Pharmaceuticals Inc., wholly owned step-down subsidiary of the Company in USA has entered into a Share Repurchase Agreement for sale of equity stake held in Avenue Therapeutics, Inc.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1485.35 -9.05 (-0.61%)
30-Dec-2025 11:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.95
Dr. Reddys Lab 1266.55
Cipla 1485.35
Zydus Lifesciences 902.85
Lupin 2082.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×